154 related articles for article (PubMed ID: 9474308)
1. DNA index and % S phase fraction in posterior uveal melanoma: a 5 year prospective study of fresh tissue using flow cytometry.
Richardson RP; Lawry L; Rees RC; Rennie IG
Eye (Lond); 1997; 11 ( Pt 5)():629-34. PubMed ID: 9474308
[TBL] [Abstract][Full Text] [Related]
2. Estimation of DNA content in uveal melanomas by flow cytometry.
Rennie IG; Rees RC; Parsons MA; Lawry J; Cottam D
Eye (Lond); 1989; 3 ( Pt 5)():611-7. PubMed ID: 2630338
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study.
Lee KH; Lee JS; Lee JH; Kim SW; Suh C; Kim WK; Kim SH; Min YI; Kim BS; Park KC; Lee MS; Sun HS
Br J Cancer; 1999 Apr; 79(11-12):1727-35. PubMed ID: 10206284
[TBL] [Abstract][Full Text] [Related]
4. DNA index and S phase fraction in uveal malignant melanomas.
Hodge WG; Duclos AJ; Rocha G; Antecka E; Baines MG; Corriveau C; Brownstein S; Deschenes J
Br J Ophthalmol; 1995 Jun; 79(6):521-6. PubMed ID: 7626566
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
[TBL] [Abstract][Full Text] [Related]
6. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
Eskelinen M; Lipponen P; Nordling S
Anticancer Res; 1995; 15(5B):2279-83. PubMed ID: 8572637
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
[TBL] [Abstract][Full Text] [Related]
8. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric DNA analysis of primary cutaneous malignant melanoma.
Ohnishi K; Ishikawa H
Acta Derm Venereol; 1991; 71(6):525-8. PubMed ID: 1685836
[TBL] [Abstract][Full Text] [Related]
10. Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis.
Bratt O; Anderson H; Bak-Jensen E; Baldetorp B; Lundgren R
Urology; 1996 Feb; 47(2):218-24. PubMed ID: 8607238
[TBL] [Abstract][Full Text] [Related]
11. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction.
Nordström B; Strang P; Bergström R; Nilsson S; Tribukait B
Cancer; 1996 Nov; 78(9):1942-51. PubMed ID: 8909315
[TBL] [Abstract][Full Text] [Related]
12. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric DNA analysis as prognostic factor in human breast carcinoma.
Ottestad L; Pettersen EO; Nesland JM; Hannisdal E; Fosså SD; Tveit KM
Pathol Res Pract; 1993 May; 189(4):405-10. PubMed ID: 8351241
[TBL] [Abstract][Full Text] [Related]
14. DNA aneuploidy and low S-phase fraction as favourable prognostic signs in metastatic melanoma.
Muhonen T; Pyrhönen S; Laasonen A; Asko-Seljavaara S; Franssila K
Br J Cancer; 1991 Oct; 64(4):749-52. PubMed ID: 1911224
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of DNA ploidy as assessed with flow cytometry in uveal melanoma.
Elavathil LJ; LeRiche J; Rootman J; Gallagher RP; Phillips D
Can J Ophthalmol; 1995 Dec; 30(7):360-5. PubMed ID: 8963937
[TBL] [Abstract][Full Text] [Related]
17. Ovarian tumors of low malignant potential. Correlation of DNA index and S-phase fraction with histopathologic grade and clinical outcome.
Demirel D; Laucirica R; Fishman A; Owens RG; Grey MM; Kaplan AL; Ramzy I
Cancer; 1996 Apr; 77(8):1494-500. PubMed ID: 8608534
[TBL] [Abstract][Full Text] [Related]
18. DNA analysis of laryngeal carcinoma cells by flow cytometry: the histoclinical factors and their significance.
Dobroś W; Lackowska B; Ryś J; Niezabitowski A; Stanisz-Wallis K; Olszewski E; Modrzejewski M
J Otolaryngol; 2000 Dec; 29(6):371-6. PubMed ID: 11770146
[TBL] [Abstract][Full Text] [Related]
19. The correlation between cell surface markers and clinical features in choroidal malignant melanomas.
Lawry J; Currie Z; Smith MO; Rennie IG
Eye (Lond); 1999 Jun; 13 ( Pt 3a)():301-8. PubMed ID: 10624422
[TBL] [Abstract][Full Text] [Related]
20. Sex steroid receptors, S-phase fraction and DNA ploidy as determinants of the risk of relapse and death of female breast cancer.
Lipponen P; Eskelinen M; Papinaho S; Klemi PJ; Aaltomaa S; Kosma VM; Marin S; Syrjänen K
Anticancer Res; 1992; 12(3):677-82. PubMed ID: 1622125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
